BC
STE icon

Bowman & Company’s Steris STE Stock Holding History

Bowman & Company’s Portfolio STE Stock Details STE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.17M Sell
4,613
-47
-1% -$11.8K 0.49% 56
2025
Q3 		$1.15M Sell
4,660
-39
-0.8% -$9.34K 0.49% 56
2025
Q2 		$1.13M Buy
4,699
+304
+7% +$70.8K 0.5% 57
2025
Q1 		$997K Buy
4,395
+400
+10% +$88K 0.49% 61
2024
Q4 		$822K Sell
3,995
-30
-0.7% -$6.58K 0.42% 66
2024
Q3 		$978K Buy
4,025
+425
+12% +$99.4K 0.51% 61
2024
Q2 		$792K Buy
3,600
+253
+8% +$55K 0.46% 64
2024
Q1 		$754K Buy
3,347
+7
+0.2% +$1.58K 0.46% 64
2023
Q4 		$736K Buy
3,340
+223
+7% +$47.2K 0.51% 58
2023
Q3 		$685K Buy
3,117
+692
+29% +$157K 0.55% 54
2023
Q2 		$547K Buy
2,425
+51
+2% +$10.2K 0.41% 58
2023
Q1 		$454K Buy
2,374
+643
+37% +$124K 0.33% 61
2022
Q4 		$320K Sell
1,731
-563
-25% -$99K 0.25% 71
2022
Q3 		$381K Buy
2,294
+117
+5% +$23.8K 0.35% 59
2022
Q2 		$449K Buy
+2,177
New +$491K 0.39% 58

Other funds holding STE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bowman & Company's STE Position: Q4 2025 in Review

Bowman & Company reduced its Steris (STE) stake by 1% in Q4 2025, selling an estimated $11.8K and leaving 4,613 shares worth $1.17M. The position accounts for 0.49% of the portfolio, ranked #56.

Bowman & Company first reported a position in STE in Q2 2022 and has held it in 15 quarters since. 895 funds tracked by Wall St. Rank hold STE as of Q4 2025.

  • Bowman & Company held 4,613 shares of Steris worth $1.17M as of Q4 2025.
  • Bowman & Company sold 47 Steris shares in Q4 2025, an estimated $11.8K.
  • Steris made up 0.49% of Bowman & Company's portfolio in Q4 2025, its #56 holding.
  • Bowman & Company first reported a position in Steris in Q2 2022 and has held it in 15 quarters since.
  • 895 funds tracked by Wall St. Rank held Steris as of Q4 2025.

Based on Bowman & Company's 13F filing for Q4 2025, filed 23 Jan 2026.